Physicochemical Properties
| Molecular Formula | C18H20D9CLN2O |
| Molecular Weight | 333.94 |
| Related CAS # | Levobupivacaine hydrochloride;27262-48-2 |
| Synonyms | Levobupivacaine-d9; (S)-(–)-Bupivacaie-d9(hydrochloride) |
| Storage |
Powder-20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month |
| Shipping Condition | Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs) |
Biological Activity
| References |
[1]. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019 Feb;53(2):211-216. [2]. Levobupivacaine: a review of its use in regional anaesthesia and pain management. Drugs. 2010 Apr 16;70(6):761-91. [3]. Levobupivacaine Induces Ferroptosis by miR-489-3p/SLC7A11 Signaling in Gastric Cancer. Front Pharmacol. 2021 Jun 9;12:681338. [4]. Comparative effects of levobupivacaine and racemic bupivacaine on excitotoxic neuronal death in culture and N-methyl-D-aspartate-induced seizures in mice. Eur J Pharmacol. 2005 Aug 22;518(2-3):111-5. |
Solubility Data
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 2.9945 mL | 14.9727 mL | 29.9455 mL | |
| 5 mM | 0.5989 mL | 2.9945 mL | 5.9891 mL | |
| 10 mM | 0.2995 mL | 1.4973 mL | 2.9945 mL |